Comparing Nd:YAG Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy
NCT ID: NCT02474238
Last Updated: 2018-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2015-05-31
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sequential Laser Iridotomy Using Argon and Q-Switched 532 nm Frequency Doubled Neodymium Yag Laser: A Pilot Study
NCT00452998
Laser Iridotomy Versus Surgical Iridectomy in Early Angle Closure
NCT01468103
Anti-Aggregative Therapy and Laser Iridectomy
NCT00426400
Clinical Study of LPI With Different Laser Wavelengths
NCT02901730
The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Primary Open Angle Glaucoma
NCT04912362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The sequential technique
By using the double frequency YAG laser to make the initial bore and the Nd:YAG laser to complete the perforation on iris.
The sequential technique
By using 'the double frequency YAG laser' to make the initial bore and 'the Nd:YAG laser' to complete the perforation on iris.
The pure Nd:YAG laser technique
By using the pure Nd:YAG to make a complete perforation on iris.
The pure Nd:YAG laser technique
By using 'the pure Nd:YAG laser' to make a complete perforation on iris.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The sequential technique
By using 'the double frequency YAG laser' to make the initial bore and 'the Nd:YAG laser' to complete the perforation on iris.
The pure Nd:YAG laser technique
By using 'the pure Nd:YAG laser' to make a complete perforation on iris.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* primary angle closure glaucoma or
* primary angle closure or
* primary angle closure suspect (needed repeated pupil dilation) or
* fellow eyes of acute angle closure crisis, and
* Age of at least 18 years, and
* Dark iris patients (only black and dark brown color)
Exclusion Criteria
* Active conjunctiva or corneal infection or inflammation
* Active anterior uveitis
* History of any prior laser treatment
* History intraocular surgery
* Eye with corneal scar
* Corneal haziness obscure iridotomy site
* Endothelial cell count less than 1000 cells/mm2 (pre-laser)
* Iris color other than black or dark brown
* Inability to sit at the slit lamp to have laser done
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prince of Songkla University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weerawat Kiddee
Asst.Prof.Weerawat Kiddee
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Asst.Prof.Weerawat Kiddee, MD
Role: PRINCIPAL_INVESTIGATOR
Prince of Songkla University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Weerawat Kiddee
Hat Yai, Changwat Songkhla, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC-58-093-02-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.